Buprenorphine in the HIV Primary Care Setting

First Page		Document Content
Date: 2007-05-01 12:40:36 Organic chemistry Biology CCR5 Vicriviroc Monogram Biosciences Antiretroviral drug HIV AIDS Aplaviroc HIV/AIDS Chemistry Entry inhibitors		Buprenorphine in the HIV Primary Care Setting Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 431,74 KB Share Document on Facebook

	Monogram Data Management Policy Collaborations and data procurement: The data underlying published reports in the scientific literature by Monogram Biosciences can be accessed to support further scientific investigations DocID: 197rS - View Document
	PDF Document DocID: 17saC - View Document
	Consultation Decision Analytic Protocol to guide the assessment of a pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc DocID: VMeV - View Document
	MSAC Application 1174: Consultation Decision Analytic Protocol (DAP) to guide the assessment of a pathology test to determine if a patient has been infected with CCR5 tropic DocID: VpV4 - View Document
	Public Summary Document Application No[removed]Assessment of viral tropism testing of HIV to inform treatment with maraviroc Applicant: ViiV Healthcare DocID: V4Wf - View Document